To identify patients suspected of having Latent autoimmune diabetes in adults (LADA) and to see if Cpeptide can be used as an effective tool in screening of LADA, reserving definite but more expensive investigation i.e measurement of autoantibodies for high suspect cases.
100 patients diagnosed with type2 DM with age at onset >25yrs and poor glycemic control after adequate compliance to diet and treatment were enrolled in the study group. 100 healthy subjects appropriately matched formed the control group. We measured fasting C-Peptide levels in all the subjects. A qualitative test for glutamic acid decarboxylase antibody (GADA) was performed on suspected LADA group. All the subjects were followed up and repeat C-Peptide levels were done after 6 months.
Out of 100, a total of 34 patients measured low C-Peptide levels (¡Ý0.7ng/dl) and raised suspicion of some autoimmune component in them. They were classified as suspected LADA group. Rest of the 66 patients was grouped as classic type2 diabetes patients. Though GADA came out to be negative but compared with classic type2 diabetics, suspected LADA patients had a younger age at onset (p= 0.014), lower incidence of hypertension (p=0.002), lower body mass index (p=0.000), lower TG levels(p=0.000), higher HDL levels (p=0.028), lower fasting insulin (p=0.003) and C-peptide levels (p=0.000), lower insulin resistance (p=0.000) and poorer beta cell function index (p= 0.004). After 6 months follow up, patients in suspected LADA group demonstrated a decreasing trend in their C-Peptide levels.
Although a quantitative analysis of GADA and other auto-antibodies may be useful in diagnosing LADA but due to their high cost, a more practical and economical approach is needed for screening these patients. One such tool can be serial measurement of C-Peptide levels.Early identification of LADA is important because management strategy for these patients is entirely different from type 2 diabetics.
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Mechanisms And Management of Diabetes Mellitus

Bruno Lopes
Topiwala National Medical College, Mumbai.
The early symptoms of untreated diabetes mellitus are related to the elevated blood glucose levels. Excess glucose in the blood ultimately results in high levels of glucose being present in the urine (glucosuria). Diabetes Mellitus is a heterogeneous disorder affecting almost all the metabolic processes in the body due to relative or absolute deficiency of insulin. If uncontrolled for many years, it can lead to more serious health problems:
• Blood vessel damage within the eye retinopathy leading to blindness. • Kidney disease (nephropathy) or kidney failure.
• Nerve damage (neuropathy) especially of the hands and feet, causing, numbness and weakness.
• Narrowing of the blood vessels due to cholesterol deposits (atherosclerosis) increasing the risk of heart attack, stroke and poor blood flow in the legs. The estimation of glycosylated hemoglobin was studied as it gives an estimate of the glycemic level over a long period at the same time the extent of hyperlipidemia was studied for the betterment of patient so as to help the physician to develop a diet plan with appropriate diet, therapy and exercise.
30 male patients of Nair hospital with uncontrolled diabetes mellitus who were not on medication for the past 1 year and were deprived of ketonuria, myocardial infarction, retinopathy, severe illness and whose creatinine concentration was greater than 175 micromol/L were selected and tested for fasting glucose, glycosylatd hemoglobin, cholesterol and triglycerides The study was designed to find out the correlation between lipid peroxidation, lipoprotein levels and type 2 diabetes mellitus. Degree of lipid peroxidation was measured in terms of malondialdehyde (MDA) along with lipid profile and blood glucose in type 2 diabetes mellitus.
Total 42 known diabetic patients and 22 non-diabetic controls were studied. The biochemical parameters such as blood glucose, lipid profile (total cholesterol, triglycerides, HDL-cholesterol, VLDL-cholesterol & LDL-cholesterol) & lipid peroxidation level were evaluated in both groups of type 2 diabetic subjects.
There are significant increases (p<0.05) in the lipid peroxidation (MDA) and lipid profile except HDL cholesterol which is decreased, have been found in diabetic groups as compared to normal controls. Other finding observed that the level of lipid peroxidation significantly increased (p<0.05) as per the increase in concentration of blood glucose in type 2 diabetic subjects.
It is concluded that good metabolic control of hyperglycemia may prevent the alteration of lipid peroxidation and the lipid metabolism, which may help in good prognosis and preventing manifestation of vascular and secondary complication in diabetes mellitus. The present study has been carried out in 50 subjects, out of which 30 were Diabetic (Type 2) and 20 were age matched control healthy subjects. Biochemical investigations postprandial blood sugar, Liupid & lipoprotein profile, activity of PON & MDA were carried out in postprandial state. We observed a significant reduction in PON activity with decreased HDL (P<0.001). The reduction in PON activity is further confirmed by elevation of Prooxidant P-MDA. Therefore it is concluded that decrease in PON activity alongwith HDL could be considered as diagnostic marker for cardiovascular diseases (CVD) in NIDDM subjects. Glycosylated Hemiglobin assay is a poweful research tool that is unique as a retrospective index of glucose control over time in patients with diabetes. Glycosylated hemoglobin assay co-rrelates with mean plasma glucose levels detemined over preceding 2-3 months. This assay tells the degree of blood glucose control in idabetic patients. Hb Aic allows clinicians to identify patients with relatively poor glycemia control and is conjugation with glucose monitoning, dietary instruction and adjustment of drug or insulin regimens can lead to improvemenat in glycemia contorl. In nutshell, present study was carried out with aim to make aware the patients with diabetes of the degree of blood glucose control by getting themselves investigated the revels of Hb A1c.
The study included 26 controls and 50 case of type II diabetes (Non-insulin dependent diabetes mellitus of either sex ( male or female) age group (40-70) yr. Glycosylated gemoglobin was measured by coloumn chromatography ( Ion-exchange temperature independent). after preparing hemosyrate where labile fraction is eliminated, hemoglobins are retained by cationic exchange resin. Hb A1c is specifically eluted after washing away Hb A1 a + 1b fraction and is quantified by semi -auto aralyser reading at 410 mm. blood glucose leuds were estimated by methods using 0-toluidine.
HbA1c Glycosylated gemoglobie is raised in patients with diabetes. Percentage of Glycosylation depends on mean blood glucose Concentration. In control group range was (3-6)% 4.28+ -3.50 (mean + -SD). In diabetic group range was 7-12 (mean + -S.D) 8.69 + -1.96.
The results of present study indicate that the hemoglobin A1c assay provides a measurement of metabolic control over time that is not other wise obtainable in the usual clinical setting. Although refinement of index. of short term glucose control may lead to better appreciation of long term control. No currcutly available single assenment is as informative about long term control as the glycosylated hemoglobin assay. Diabetes mellitus is strongly associated with oxidative stress, which can be consequence of either increased production of free radicals, reduced antioxidant defense or both. It is still not clear whether oxidative stress precedes or merely reflects diabetic complications. We have undertaken studies to determine the extent of oxidative stress in non diabetic first degree relatives of type 2 diabetic patients in an effort to understand the development of oxidative stress in type 2 diabetes.
The study included normotensive subjects with ¡Ý parent with type 2 diabetes. The activity was measured with respect to age matched controls and type 2 diabetic patients. Oxidative stress was evaluated by measuring total antioxidant potential of the plasma in terms of FRAP values and by determining erythrocyte MDA as a marker of lipid peroxidation.
The total antioxidant capacity of the plasma (FRAP) was decreased in T2DM relatives (21%) and T2DM patients (36%), the decrease was significant in both the groups. Correlating with decrease in FRAP, there was a significant increase in erythrocyte MDA in both the groups (T2DM relatives 22.3% and T2DM patients 40.44%) compared to age and sex matched control subjects
The above findings provide evidence of an association between development of oxidative stress and susceptibility to type 2 diabetes. We therefore conclude that oxidative stress precedes the development of frank diabetic state.
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Enhanced Susceptibility of Small Dense (sd)-LDL to in vitro Oxidative Modification in Type 2 Diabetic-Hyperlipidemic Subjects Recently, sd-LDL has been highlighted as a new risk factor for coronary heart disease (CHD). In the present study, we investigated the oxidative susceptibility of sd-LDL and LDL; by measuring the lipid peroxidation products and lag phase time, in type 2 diabetic-hyperlipidemic subjects.
Fasting serum samples of 58 type 2 diabetic-hyperlipidemic subjects were collected and assigned into 5 groups (A-E), depending upon their duration of treatment with atorvastatin plus fibrovast drug and individual serum total cholesterol (TC), LDL-C and sd-LDL-C values. Serum sample of 4 normolipidemic subjects were also taken for comparative study. In addition to TG, TC, LDL-C and sd-LDL-C measurement, Cu Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) in vitro oxidative susceptibility of LDL, and sd-LDL were also determined in all the groups.
The results showed that TG and TC levels in group A, B, C, D and E were -39%, -38%, +21%, +10.9%, +66% and -30%, -32%, +28%, -80%, 141 %, respectively, when compared to normal level. Similarly, LDL-C values were -20 %, +16%, +48%, +107 %, +182 % and sd-LDL-C values were + 5 %, + 11 %, + 35 %, +101 %, + 127 %, respectively, in all groups as compared to normal levels. This increase/ decrease in percentage totally depend upon treatment (atorvastatin plus fibrovast) duration. The ex vivo base line diene conjugation (BDC) levels of sad-LDL and LDL were increased in all groups. Consistent with ex vivo BDC levels of LDL and sd-LDL, susceptibility of these particle to Cu ++ -induced oxidation, as measured by their lag time, was decreased in the groups, as compared to normal levels.
The results demonstrate that due to oxidative stress, in type 2 diabetic-hyperlipidemic subjects, the ex vivo and in vitro susceptibility to oxidation was substantially increased in sd-LDL than LDL, indicating a strongest marker for clinically apparent and non apparent atherosclerosis in type 2 diabetes.
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Microalbuminuria and Oxidative Stress in Diabetes
Department of Biochemistry, Narayana Medical College, NTR University of Health Sciences
The study was undertaken to evaluate the role of microalbuminuria and oxidative stress in diabetes. Glutathione was estimated as a parameter of oxidant and GPX as an antioxidant was studied.
The study includes 25 controls with normal FBSA and PPBS and 50 diabetics having diabetic duration below 10 years in age group fo 30 to 60 years. Both saxes were included. Microalbuminuria was estimated by using Turbidometric method. Glutathione was estimated in RBC in the form of reduced GSH 5,5'-dithiobis (2-nitrobenzoic acid) DTNB is a disulfide chromogen that is readily reduced by sulfohydryl compounds to an intensively yellow compound which is measured at 412 nm. GPx is estimated by H 2 O 2 .
Glutathione values wre reduced (3.5 + 1.2) as compared to controls (5.9 + 0.36) GPX is signficantly incrased (13.4 + 50.4) as compared to controls (38.1 + 4.8) microalbuminuria values were significantly increased in diabetes (110.2 + 42.4) as compared to controls (9.53 + 3.63).
This study indicates that microalbuminuria in chronic diabetic patients may be associated with free radical damage.
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Therapeutic Application of Autologous Bone Marrow Derived Mononuclear Cells in Non-Healing Ulcers of Lower Extremity.
Nihar Ranjan Dash*, Surjya N Dash, P. Routray, Sribatsha K Mohapatra, Prakash C. Mohapatra
Bone marrow derived mesenchymal stem cells represent a promising population for supporting new clinical concepts in cellular therapy. The nonhematopoietic component of bone marrow includes multipotent mesenchymal stem cells capable of differentiating into fat, bone, muscle, cartilage and endothelium. This study was undertaken to assess the application of autologous transplantation of bone marrow derived mononuclear cells in treatment of chronic non-healing ulcers as well as to induce therapeutic angiogenesis in critical limb ischemia.
Five cases were enrolled: 3 of non-healing Diabetic foot ulcer, 1 of arteriosclerosis obliterans and 1 of non-healing burn wound. With informed consent the bone marrow mononuclear cells were harvested, cultured and injected intramuscularly into the ischemic and non-healing ulcer limbs. All of the patients were followed up for at least 4 months.
No adverse effect occurred in any recipient. In cases of non-healing diabetic ulcer and burn wound there was a trend towards decrease in ulcer size or complete wound closure by 12-16 weeks. In all the patients, after 12 weeks of MNCs transplantation there was significant increase in pain-free walking distance and ankle-brachial index. Angiographic scores were significantly improved in case of thromboangiitis obliterans.
These preliminary data in a small group of patients with non-healing ulcer and CLI indicate that autologous transplantation of bone marrow derived mononuclear cells is safe, feasible, and may improve both functional and clinical indices. Of 90 Type 2 DM patients 30 were smokers, 30 patients were ex-smoker and rest 30 were non-smoker. Plasma levels of thiobarbituric acid reactive substances (TBARS), total antioxidant activity (TAA), Vitamin E and Vitamin C were assayed in smoker, ex-smoker and non-smoker.
Among Type 2 diabetic patients (age range 42 to 73 years), TBARS was significantly increased in smoker and ex-smoker group when compared to non-smoking group. TAA, Vitamin E and Vitamin C did not show any significance. TBARS was 4.20±0.49 μmol/L, 2.86±1.64 μmol/L and 1.70±0.64 μmol/L in smoker, ex-smoker and non-smoker groups respectively. The results indicate that lipid peroxidation is increased in smoking DM patients. Ex-smoker who had gave up smoking showed less lipid peroxidation which enlightens the fact that smoking induces lipid peroxidation.
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Gestational Diabetes in Urban Slum of Kurnool City.
Radha Rani P., Sreedevi A.
Kurnool Medical College, Kurnool ( A P )
Diabetes can lead to many a complications even in otherwise healthy people. In pregnancy which is an immunoompromised state the effect ofdiabetes has many complications. However, if diagnosed early the gestational diabetes can easily be managed without any complications. Screening all the antenatal people for blood sugar estimation will significantly lower the mortality and morbidity due to diabetes.
Present study includes identification of 200 antenatal women in the urban slums of the kurnool city. All of them are screened for diabetes. The blood glucose is estimated by glucose peroxidase method .corresponding urine sugar is also estimated. All the women who showed abnormal glucose levels are asked to come for the glucose tolerance test.
19 antenatal women are diagnosed to be diabetics after the estimation of blood glucose and after detailed elicitation of the history of each woman.
With the present life style where in lot of factors like stress,anxiety nuclear family have bocome inevitable, incidence of diabetes in pregnancy is on the rise. An early detection of diabetes in pregnancy can be done by regular laboratory visits which should form the necessary component of maternal and child health care in every set up .This will definitely help not onlyin detection of gestational diabetes but aids in the effective management thereby prevenyting the complications. 1. Accuracy is often neglected area of validation 2. NGSP Level-I certification is mandatory to achieve highest accuracy for Clinical Trials 3. Minimal levels of accuracy standards should be set at national levels so that Diabetics Care can be improved. 4. NGSP certification is achievable if accuracy is taken into serioius consideration.
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Effect of LDL, VLDL and HDL Cholesterol on Blood Viscosity and Lipid Peroxidation in NIDDM Patients
Neetu Mishra 1 , Neelima Singh The objective of the present work was to assess the effect of low density lipoprotein (LDL) cholesterol, very low density lipoprotein (VLDL) cholesterol and High density lipoprotein (HDL) cholesterol on blood viscosity and lipid peroxidation in NIDDM patients.
The study was carried out in 104 subjects out of which 50 were healthy control subjects and 54 were clinically diagnosed NIDDM patients between 40-70 years of age. Patients were again sub divided into group-I ( Without complication, n=25) and group-II (With complication, n=29). The serum samples were analysed for Blood sugar, Total cholesterol, Triglyceride, HDL-C, VLDL, and LDL-C. Erythorocytes were used for estimation of lipid perxoidatoni by Malondialdehyde (MDA), Blood viscosity calculated by Merill's Formula.
Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) The level of lipid profile, EMDA and blood viscosity were significantly changed when compared with normal healthy control. The significant correlation were found between TC (r = -0.262*) , TG (r = 0.479***), LDL (r = 0.236*) and VLDL (r = 0.485***) with lipid peroxidation in group I diabetic. However there were no significant correlation found between lipid profile and blood viscosity. But in group II diabetics blood viscosity were also significantly correlated with HDL (r = -0.335**) and LDL (r = 0.426***).
The lipid profile plays an important role in blood viscosity and lipid perxoidation in NIDDM patients with or without Macro/Micro-vascular complications. To find the level of interference of cabamylated haemoglobin in glycosylaed haemoglobin in chronic renal failure with diabetic patients Sixty-three patients with CRF were recruited for this study. Twenty-nine were chronic renal patients and the remaining 34 had chronic renal failure with diabetics. Age and sex matched 33 normal individuals were selected for control study. Blood samples were collected to analyze the glycosylated haemoglobin and carbamylated haemoglobin Carbamylated haemoglobin was found to be significantly increased in Chronic Renal Failure with diabetic patients and Chronic Renal failure patients when compaired to normal individuals. Cabamylated haemoglobin was found to be increased significantly in CRF with diabetic when compaired to non diabetic CRF patients. Interference of carbomylated haemoglobin was found to be high in CRF with diabetic patients when compaired to normal individuals While analysing the glycosylated haemoglbin in Chronic renal patients, we should use a technology which can seperate the carbamylated haemoglobin from glycosylated haemoglbin, otherwise it cause a false elevation fo glycosylated haemoglobin. Recent evidences indicate that most of the nitric oxide (NO) toxicity is due to peroxynitrite (OONOâ"•), produced from the diffusion-controlled reaction between NO and the superoxide anion. Peroxynitrite interacts with lipids, DNA, and proteins via direct oxidative reactions or via indirect, radical-mediated mechanisms. Accumulating evidence suggest the key role of NO, superoxide, peroxynitrite, and downstream effectors such as PARP in the pathogenesis of diabetes and diabetic complication. The study probes the role of OONOâ"• -DNA in diabetes Native plasmid was modified by incubating pUC-18 (0.038 mM bp) in 100mM PBS buffer pH at 7.4, containing 0.01mM diethylenetriamine pentacetic acid (DTPA) with 1.2 mM PON at 37o C for 2hr. The modified DNA was characterized by UV fluorescence spectroscopy, nuclease S1 digestion, HPLC, thermal denaturation etc. Antibodies against OONOâ"• -DNA were induced in rabbits. DNA was isolated from lymphocytes of diabetic patients and healthy subjects. Immunoglobulin G was isolated on Protein AAgarose column
P5.14
Interference of Carbamylated Haemoglobin in Glycosylated Haemoglobin
The UV absorption spectra of modified DNA showed around 69% hypechromicity, generation of single strand breaks, modification of bases, decrease in Tm and change in the ellipticity of DNA. HPLC result show the formation of 8-nitroguanine in modified plasmid. Modified DNA was highly immunogenic eliciting high titre immunogen specific antibodies in rabbits. Circulating autoantibodies in diabetes showed higher recognition of OONOâ"• -DNA as compared to native form. Nitrosative lesions in human genomic DNA were immunochemically detected using anti-OONOâ"• -DNA antibodies as a probe.
The data shows preferential binding of diabetes autoantibodies to OONOâ"• -DNA in comparison with native DNA. The results suggest that peroxynitrite modification of plasmid DNA cause perturbations, resulting in the generation of neo-epitopes and making it potential immunogen. The DNA modified with peroxynitrite may be one of the factors for the induction of circulating diabetes anti-DNA autoantibodies. Six plants (Morus indica, Costus speciosus, Ficus racemosa ,Aegle marmelos Tinospora Cardifolia Gymnema Sylvestrae )and four fiber sources ( wheat bran, oats, barley and psyllium) were screened for their potential hypoglycemic effects by in vitro model systems measuring glucose adsorption capacity, a amylase inhibition, glucose diffusion retardation (GDRI) and starch digestibility (SDI). Glycemic responses to foods containing barley, morus and gymnema were studied in Type 2 diabetics. Among fibers psyllium, barley and oats exhibited higher glucose adsorption. The medicinal samples also could bind glucose effectively, and the amounts of glucose bound were dependent on the concentration of the sample and glucose. Factors affecting glucose adsorption capacity were water absorption, water holding capacity and swelling power. Morus and Costus significantly inhibited á -amylase activity and glucose diffusion as the GDRI was significantly high (p<0.05) compared to the control and dietary fibers. Significant reductions ( p<0.05) in SDI was observed with Morus incorporation at levels 2 & 4 % in chapathi, indicating its ability to inhibit enzymes of carbohydrate digestion. Post-prandial glycemia was significantly (p<0.05) reduced after consumption of barley incorporated foods -breads & chapathi in type 2 diabetic subjects ( n= 12). The data indicate that individual functional characteristics should be considered when selecting a functional ingredient. Medicinal plants have scope for utilization as functional foods to cater to the therapeutic needs of diabetics & other target groups. To assess the role of PPARã, IRS-1 and calpain-10 gene polymorphism in T2DM in North Indians.
The study included 150 nondiabetics and 150 diabetics. Weight, height, % body fat, waist to hip ratio (WHR), blood pressure and duration of the disease were recorded. Fasting and random plasma glucose, serum triglycerides and free fatty acids were estimated by standard procedures. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Diabetics demonstrated statistically significant differences in age, weight, body mass index, WHR, blood pressure, fasting and random plasma glucose and triglycerides. Frequency of PPARã 34G, PPARã 1431T, IRS-1 2911A and calpain-10 SNP-19 allele-2 in nondiabetics was 0.117, 0.114, 0.06 and 0.536 versus 0.093, 0.1, 0.1 and 0.57 in diabetics, respectively. None of the polymorphism demonstrated significant change between nondiabetics and diabetics.
Gene polymorphism of PPARã C34G, PPARã C1431T, IRS-1 G2911A and calpain-10 (SNP-19) does not play any role in the pathogenesis of T2DM in North Indians.
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Study of Serum Lipid Peroxide and its Association with Vitamin C in Diabetes Mellitus
M.M.Suchitra
Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh.
Hyperglycemia induced oxidative stress and impaired anti-oxidant defense have been suggested as contributory factors for initiation and progression of complications in diabetes mellitus which exacerbate cardiovascular complications. Dyslipidemia of diabetes mellitus are major risk factors for the development of atherosclerosis. Lipid peroxidation and oxidative modification of low density lipoproteins have also been implicated in the development of atherosclerosis. Vitamin C protects against oxidative damage and may be regarded as an antioxidant biomarker. The current study was taken up to evaluate the oxidant and antioxidant status in diabetes mellitus by measuring the products of lipid peroxidation -serum LPO and the antioxidant vitamin C and to study the association of LPO and vitamin C in a case control study. controls. Lipid peroxide are measured as TBARS [thiobarbituric acid reactive substances]by spectrophotometry, vitamin C is estimated by photometric method, cholesterol, triglycerides and HDL are estimated by cholesterol oxidase-peroxidase, glycerol phosphate oxidase / peroxidase and phosphotungstic acid precipitating method using commercial kits on Beckman Synchron CX9 autoanalyzer.
We found highly significant elevated cholesterol, triglyceride, LDL (p<0.001), significantly elevated VLDL, significantly decreased HDL p<0.05), LPO was highly significantly elevated with a similar highly significant decrease in vitamin C (p<0.001) in the study group when compared to control group. We found a highly significant decrease in the Tgl:LPO, VLDL:LPO ratio in the study group (p<0.001), a significant increase in the ratio of Chol: HDL (p<0.001), a highly significant increase in the LDL: HDL ratio (p<0.001). We found no significant correlation between LPO and triglycerides, LPO and VLDL, LDL and HDL. A significant correlation was found between LPO and Vitamin C and between cholesterol and HDL (p<0.05) in the study group.
The present study found a significant correlation between elevated LPO levels and a decrease in vitamin C levels indicating oxidative stress associated with a depleted antioxidant status in diabetes mellitus.
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Effect of hyperglycemia on TNF-α α α α α levels in patients with Type 2 Diabetes Diabetes mellitus has reached epidemic proportions and affects more than 170 million individuals worldwide. Global estimates for the eyar 2010 predict a further growth of almost 50%. In recent past, role of inflammation in causation of both Diabetes and its complications has gained acceptance. Initially, hyperglycemia was thought to be the factor causing inflammation, but recently, obesity has gained attraction as probable cause of inflammation.
The objective of this study was to assess the levels of markers of inflammation in Diabetic patients, with uncontrolled hyperglycemia, before and after treatment with Oral hypoglycemic agents or insulin.
Blood samples were collected from 30 Type 2 Diabetes patients presenting to J.N.M.C.H. endocrinology O.P.D. Also, age matched controls were taken from healthy volunteers. Samples were taken before treatment, after 24 weeks and after 48 weeks of treatment. TNF-a levels were assessed in sera using ELISA.
The levels of TNF-α were elecated in diabetic patients and were significantly reduced after treatment. In diabetic individuals, TNF-α was 40 fold higher than healthy volunteers. After 24 weeks of treatment, there was 2.5 fold decrease in levels of TNF-α. Maximum reduction was seen in first 24 weeks, though levels were further reduced afrer 48 weeks.
Thus, the results indicate that hyperglycemia significantly causes increase in inflammagtory markers like TNF-α.
